Literature DB >> 19265827

Getting a handle on Huntington's disease: the case for cholesterol.

Masahisa Katsuno1, Hiroaki Adachi, Gen Sobue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19265827     DOI： 10.1038/nm0309-253

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

Review 1.  Cholesterol in Alzheimer's disease.

Authors:  Leila A Shobab; Ging-Yuek R Hsiung; Howard H Feldman
Journal:  Lancet Neurol       Date:  2005-12       Impact factor: 44.182

2.  Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

Authors:  Tiina J Kotti; Denise M O Ramirez; Brad E Pfeiffer; Kimberly M Huber; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice.

Authors:  Sandra Andersson; Nina Gustafsson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

Review 4.  Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.

Authors:  Rachel Butler; Gillian P Bates
Journal:  Nat Rev Neurosci       Date:  2006-10       Impact factor: 34.870

5.  A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release.

Authors:  M Michikawa; J S Gong; Q W Fan; N Sawamura; K Yanagisawa
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

6.  Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.

Authors:  Andreas Papassotiropoulos; Johannes R Streffer; Magdalini Tsolaki; Simon Schmid; Dietmar Thal; Francesca Nicosia; Vassiliki Iakovidou; Alessia Maddalena; Dieter Lütjohann; Estifanos Ghebremedhin; Thomas Hegi; Thomas Pasch; Muriel Träxler; Annette Brühl; Luisa Benussi; Giuliano Binetti; Heiko Braak; Roger M Nitsch; Christoph Hock
Journal:  Arch Neurol       Date:  2003-01

7.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.

Authors:  L Dupuis; P Corcia; A Fergani; J-L Gonzalez De Aguilar; D Bonnefont-Rousselot; R Bittar; D Seilhean; J-J Hauw; L Lacomblez; J-P Loeffler; V Meininger
Journal:  Neurology       Date:  2008-01-16       Impact factor: 9.910

8.  Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.

Authors:  Valerio Leoni; Caterina Mariotti; Sarah J Tabrizi; Marta Valenza; Edward J Wild; Susie M D Henley; Nicola Z Hobbs; Maria Luisa Mandelli; Marina Grisoli; Ingemar Björkhem; Elena Cattaneo; Stefano Di Donato
Journal:  Brain       Date:  2008-09-04       Impact factor: 13.501

9.  Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

Authors:  Marta Valenza; Dorotea Rigamonti; Donato Goffredo; Chiara Zuccato; Simone Fenu; Laure Jamot; Andrew Strand; Alessia Tarditi; Ben Woodman; Marco Racchi; Caterina Mariotti; Stefano Di Donato; Alberto Corsini; Gillian Bates; Rebecca Pruss; James M Olson; Simonetta Sipione; Marzia Tartari; Elena Cattaneo
Journal:  J Neurosci       Date:  2005-10-26       Impact factor: 6.167

10.  Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.

Authors:  Marta Valenza; Jeffrey B Carroll; Valerio Leoni; Lisa N Bertram; Ingeman Björkhem; Roshni R Singaraja; Stefano Di Donato; Dieter Lutjohann; Michael R Hayden; Elena Cattaneo
Journal:  Hum Mol Genet       Date:  2007-07-05       Impact factor: 6.150
View more
  9 in total

1.  Neuroprotection and brain cholesterol biosynthesis in Huntington's disease.

Authors:  Marta Valenza; Elena Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-31       Impact factor: 11.205

2.  Modeling cholesterol metabolism by gene expression profiling in the hippocampus.

Authors:  Christopher M Valdez; Clyde F Phelix; Mark A Smith; George Perry; Fidel Santamaria
Journal:  Mol Biosyst       Date:  2011-03-30

Review 3.  Membrane rafts in Alzheimer's disease beta-amyloid production.

Authors:  Kulandaivelu S Vetrivel; Gopal Thinakaran
Journal:  Biochim Biophys Acta       Date:  2010-03-18

4.  Assessment of cholesterol homeostasis in the living human brain.

Authors:  Ahmed Haider; Chunyu Zhao; Lu Wang; Zhiwei Xiao; Jian Rong; Xiaotian Xia; Zhen Chen; Stefanie K Pfister; Natalia Mast; Eylan Yutuc; Jiahui Chen; Yinlong Li; Tuo Shao; Geoffrey I Warnock; Alyaa Dawoud; Theresa R Connors; Derek H Oakley; Huiyi Wei; Jinghao Wang; Zhihua Zheng; Hao Xu; April T Davenport; James B Daunais; Richard S Van; Yihan Shao; Yuqin Wang; Ming-Rong Zhang; Catherine Gebhard; Irina Pikuleva; Allan I Levey; William J Griffiths; Steven H Liang
Journal:  Sci Transl Med       Date:  2022-10-05       Impact factor: 19.319

5.  Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.

Authors:  Valerio Leoni; Jeffrey D Long; James A Mills; Stefano Di Donato; Jane S Paulsen
Journal:  Neurobiol Dis       Date:  2013-04-01       Impact factor: 5.996

6.  Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.

Authors:  Jane Y Chen; Conny Tran; Lin Hwang; Gang Deng; Michael E Jung; Kym F Faull; Michael S Levine; Carlos Cepeda
Journal:  J Huntingtons Dis       Date:  2016

7.  Altered expression of 3-betahydroxysterol delta-24-reductase/selective Alzheimer's disease indicator-1 gene in Huntington's disease models.

Authors:  Athina Samara; Mariarita Galbiati; Paola Luciani; Cristiana Deledda; Elio Messi; Alessandro Peri; Roberto Maggi
Journal:  J Endocrinol Invest       Date:  2014-06-11       Impact factor: 4.256

8.  Longitudinal analysis of premotor anthropometric and serological markers of Parkinson's disease.

Authors:  Katsunori Yokoi; Makoto Hattori; Yuki Satake; Yasuhiro Tanaka; Maki Sato; Atsushi Hashizume; Akihiro Hori; Motoshi Kawashima; Akihiro Hirakawa; Hirohisa Watanabe; Masahisa Katsuno
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

9.  Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease.

Authors:  Jun Wan Shin; Aram Shin; Seri S Park; Jong-Min Lee
Journal:  Mol Ther Methods Clin Dev       Date:  2022-03-04       Impact factor: 6.698
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.